Literature DB >> 20195936

[Pathophysiology of sporadic Parkinson's disease].

H Braak1, K Del Tredici.   

Abstract

Sporadic Parkinson's disease is a multisystem disorder that involves predisposed nerve cell types in circumscribed regions of the entire human nervous system (peripheral, enteric, and central nervous systems). A recent staging procedure for the pathological process proposes that, in the brain, the formation of intraneuronal Lewy bodies and Lewy neurites begins at two sites and continues in a topographically predictable sequence in 6 stages, during which components of the olfactory, autonomic, limbic, and somatomotor systems become progressively involved. In stages 1 - 2, the Lewy body pathology is confined to the medulla oblongata/pontine tegmentum and anterior olfactory structures. In stages 3 - 4, the substantia nigra, other nuclei of the basal mid- and forebrain, and the mesocortex become the focus of initially subtle and, then, severe changes. During this phase, the illness probably becomes clinically manifest. In the final stages 5 - 6, the lesions appear in the neocortex.

Entities:  

Mesh:

Year:  2010        PMID: 20195936     DOI: 10.1055/s-0029-1245179

Source DB:  PubMed          Journal:  Fortschr Neurol Psychiatr        ISSN: 0720-4299            Impact factor:   0.752


  6 in total

1.  Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy.

Authors:  Brinda Desai Bradaric; Aditiben Patel; Julie A Schneider; Paul M Carvey; Bill Hendey
Journal:  J Neural Transm (Vienna)       Date:  2011-07-12       Impact factor: 3.575

Review 2.  Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.

Authors:  Mathias Jucker; Lary C Walker
Journal:  Ann Neurol       Date:  2011-10       Impact factor: 10.422

Review 3.  Interaction between α-synuclein and other proteins in neurodegenerative disorders.

Authors:  Kurt A Jellinger
Journal:  ScientificWorldJournal       Date:  2011-10-24

Review 4.  Interaction between pathogenic proteins in neurodegenerative disorders.

Authors:  Kurt A Jellinger
Journal:  J Cell Mol Med       Date:  2012-06       Impact factor: 5.310

Review 5.  Autonomic Function in Patients With Parkinson's Disease: From Rest to Exercise.

Authors:  Jeann L Sabino-Carvalho; James P Fisher; Lauro C Vianna
Journal:  Front Physiol       Date:  2021-03-19       Impact factor: 4.566

6.  Autonomic factors do not underlie the elevated self-disgust levels in Parkinson's disease.

Authors:  Vasileia Aristotelidou; Marianna Tsatali; Paul G Overton; Ana B Vivas
Journal:  PLoS One       Date:  2021-09-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.